New York Life Investment Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,384
Closed -$970K 799
2025
Q3
$970K Sell
15,384
-111
-0.7% -$7.75K 0.01% 664
2025
Q2
$1.16M Sell
15,495
-356
-2% -$28K 0.01% 619
2025
Q1
$1.4M Sell
15,851
-475
-3% -$44.9K 0.01% 600
2024
Q4
$1.49M Sell
16,326
-129
-0.8% -$13.2K 0.01% 597
2024
Q3
$1.84M Sell
16,455
-183
-1% -$18.3K 0.02% 593
2024
Q2
$1.63M Buy
16,638
+36
+0.2% +$3.57K 0.02% 600
2024
Q1
$1.66M Sell
16,602
-824
-5% -$72.5K 0.02% 579
2023
Q4
$1.57M Buy
17,426
+219
+1% +$17.5K 0.02% 583
2023
Q3
$1.32M Buy
17,207
+39
+0.2% +$3.24K 0.01% 581
2023
Q2
$1.44M Buy
17,168
+58
+0.3% +$4.72K 0.02% 564
2023
Q1
$1.44M Sell
17,110
-117
-0.7% -$10K 0.02% 566
2022
Q4
$1.4M Sell
17,227
-372
-2% -$30K 0.02% 578
2022
Q3
$1.25M Sell
17,599
-786
-4% -$70.6K 0.02% 586
2022
Q2
$1.65M Buy
+18,385
New +$1.9M 0.02% 545

Other funds holding EMN

New York Life Investment Management's EMN Position: Q4 2025 in Review

New York Life Investment Management sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 15,384 shares — an estimated $970K sold.

New York Life Investment Management first reported a position in EMN in Q2 2022 and held it in 14 quarters. The position peaked at $1.84M in Q3 2024. 632 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • New York Life Investment Management reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 15,384 Eastman Chemical shares in Q4 2025, an estimated $970K.
  • New York Life Investment Management first reported a position in Eastman Chemical in Q2 2022 and held it in 14 quarters.
  • New York Life Investment Management's Eastman Chemical position peaked at $1.84M in Q3 2024.
  • 632 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.